{"id":2118,"date":"2026-06-19T06:35:34","date_gmt":"2026-06-19T10:35:34","guid":{"rendered":"https:\/\/sites.nd.edu\/pdnano\/?p=2118"},"modified":"2026-06-19T06:35:35","modified_gmt":"2026-06-19T10:35:35","slug":"pdnano-lab-awarded-biph-technology-bridge-fund-for-ovarian-cancer-nanomedicine","status":"publish","type":"post","link":"https:\/\/sites.nd.edu\/pdnano\/?p=2118","title":{"rendered":"pdnano Lab Awarded BIPH Technology Bridge Fund for Ovarian Cancer Nanomedicine"},"content":{"rendered":"

Berthiaume Institute for Precision Health \u00b7 Technology Bridge Fund<\/p>\n

\"\"<\/p>\n

We’re delighted to announce that the pdnano lab has received a Berthiaume Institute for Precision Health (BIPH) Technology Bridge Fund<\/strong> award. The Technology Bridge program<\/a> supports promising precision-health projects in generating the additional preliminary data needed to\u00a0 strengthen high-impact grant resubmissions.<\/p>\n

The funded project \u2014 Multispecific Bridge-Nanoparticle Loading and T-Cell Engagement for Refractory Ovarian Cancer<\/em> \u2014 is led by PI Prakash D. Nallathamby<\/strong> (BIPH) in collaboration with Co-PI Sharon Stack<\/strong> (Harper Cancer Research Institute). It advances a nanoparticle platform designed to recruit a patient’s own immune cells against ovarian tumor cells, a strategy aimed at one of the most treatment-resistant cancers in women.<\/p>\n

Building on proof-of-principle results from the lab’s broader oncology pipeline, the Bridge project will generate targeted preliminary datasets that directly address reviewer feedback from a prior CDMRP Ovarian Cancer Research Program submission. The work will position the team for a strengthened resubmission to the FY26 OCRP Pilot Award and a planned NIH R21.<\/p>\n

We thank BIPH for its support and look forward to sharing our progress.<\/p>\n","protected":false},"excerpt":{"rendered":"

Berthiaume Institute for Precision Health \u00b7 Technology Bridge Fund We’re delighted to announce that the pdnano lab has received a Berthiaume Institute for Precision Health (BIPH) Technology Bridge Fund award. The Technology Bridge program supports promising precision-health projects in generating the additional preliminary data needed to\u00a0 strengthen high-impact grant resubmissions. The funded project \u2014 Multispecific … <\/p>\n

Continue reading »<\/a><\/p>\n","protected":false},"author":2672,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405093,39411,313538,311330],"tags":[405092,405112,405107,405111],"class_list":["post-2118","post","type-post","status-publish","format-standard","hentry","category-berthiaume-institute-for-precision-health","category-harper-cancer-research-institute","category-hybrid-nanoparticles","category-metastatic-cancer-cells","tag-berthiaume-institute-for-precision-health","tag-nallathambylab-2","tag-nanomedicine","tag-notredameresearch"],"yoast_head":"\npdnano Lab Awarded BIPH Technology Bridge Fund for Ovarian Cancer Nanomedicine - Nallathamby Laboratory<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sites.nd.edu\/pdnano\/?p=2118\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"pdnano Lab Awarded BIPH Technology Bridge Fund for Ovarian Cancer Nanomedicine - Nallathamby Laboratory\" \/>\n<meta property=\"og:description\" content=\"Berthiaume Institute for Precision Health \u00b7 Technology Bridge Fund We’re delighted to announce that the pdnano lab has received a Berthiaume Institute for Precision Health (BIPH) Technology Bridge Fund award. The Technology Bridge program supports promising precision-health projects in generating the additional preliminary data needed to\u00a0 strengthen high-impact grant resubmissions. The funded project \u2014 Multispecific … Continue reading »\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sites.nd.edu\/pdnano\/?p=2118\" \/>\n<meta property=\"og:site_name\" content=\"Nallathamby Laboratory\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/prakashdn\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-19T10:35:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-19T10:35:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sites.nd.edu\/pdnano\/files\/2026\/06\/scientific_nanoparticle_targeting_and_fluorescence_mg-cropped.png\" \/>\n\t<meta property=\"og:image:width\" content=\"596\" \/>\n\t<meta property=\"og:image:height\" content=\"711\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Prakash\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@prakashdn\" \/>\n<meta name=\"twitter:site\" content=\"@prakashdn\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Prakash\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2118#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2118\"},\"author\":{\"name\":\"Prakash\",\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/#\\\/schema\\\/person\\\/3bec2d9fbd957b23abd53a0a5445b4f0\"},\"headline\":\"pdnano Lab Awarded BIPH Technology Bridge Fund for Ovarian Cancer Nanomedicine\",\"datePublished\":\"2026-06-19T10:35:34+00:00\",\"dateModified\":\"2026-06-19T10:35:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2118\"},\"wordCount\":189,\"image\":{\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2118#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/sites.nd.edu\\\/pdnano\\\/files\\\/2026\\\/06\\\/scientific_nanoparticle_targeting_and_fluorescence_mg-cropped-251x300.png\",\"keywords\":[\"Berthiaume Institute for Precision Health\",\"Nallathambylab\",\"Nanomedicine\",\"NotreDameResearch\"],\"articleSection\":[\"Berthiaume Institute for Precision Health\",\"Harper Cancer Research Institute\",\"Hybrid nanoparticles\",\"metastatic cancer cells\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2118\",\"url\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2118\",\"name\":\"pdnano Lab Awarded BIPH Technology Bridge Fund for Ovarian Cancer Nanomedicine - Nallathamby Laboratory\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2118#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2118#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/sites.nd.edu\\\/pdnano\\\/files\\\/2026\\\/06\\\/scientific_nanoparticle_targeting_and_fluorescence_mg-cropped-251x300.png\",\"datePublished\":\"2026-06-19T10:35:34+00:00\",\"dateModified\":\"2026-06-19T10:35:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/#\\\/schema\\\/person\\\/3bec2d9fbd957b23abd53a0a5445b4f0\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2118#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2118\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2118#primaryimage\",\"url\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/files\\\/2026\\\/06\\\/scientific_nanoparticle_targeting_and_fluorescence_mg-cropped.png\",\"contentUrl\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/files\\\/2026\\\/06\\\/scientific_nanoparticle_targeting_and_fluorescence_mg-cropped.png\",\"width\":596,\"height\":711},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?p=2118#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"pdnano Lab Awarded BIPH Technology Bridge Fund for Ovarian Cancer Nanomedicine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/#website\",\"url\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/\",\"name\":\"Modular Nanotechnologies and Nanomaterials\",\"description\":\"Modular and scalable nanotechnology for imaging, sensing and therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/#\\\/schema\\\/person\\\/3bec2d9fbd957b23abd53a0a5445b4f0\",\"name\":\"Prakash\",\"url\":\"https:\\\/\\\/sites.nd.edu\\\/pdnano\\\/?author=2672\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"pdnano Lab Awarded BIPH Technology Bridge Fund for Ovarian Cancer Nanomedicine - Nallathamby Laboratory","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sites.nd.edu\/pdnano\/?p=2118","og_locale":"en_US","og_type":"article","og_title":"pdnano Lab Awarded BIPH Technology Bridge Fund for Ovarian Cancer Nanomedicine - Nallathamby Laboratory","og_description":"Berthiaume Institute for Precision Health \u00b7 Technology Bridge Fund We’re delighted to announce that the pdnano lab has received a Berthiaume Institute for Precision Health (BIPH) Technology Bridge Fund award. The Technology Bridge program supports promising precision-health projects in generating the additional preliminary data needed to\u00a0 strengthen high-impact grant resubmissions. The funded project \u2014 Multispecific … Continue reading »","og_url":"https:\/\/sites.nd.edu\/pdnano\/?p=2118","og_site_name":"Nallathamby Laboratory","article_publisher":"https:\/\/www.facebook.com\/prakashdn","article_published_time":"2026-06-19T10:35:34+00:00","article_modified_time":"2026-06-19T10:35:35+00:00","og_image":[{"width":596,"height":711,"url":"https:\/\/sites.nd.edu\/pdnano\/files\/2026\/06\/scientific_nanoparticle_targeting_and_fluorescence_mg-cropped.png","type":"image\/png"}],"author":"Prakash","twitter_card":"summary_large_image","twitter_creator":"@prakashdn","twitter_site":"@prakashdn","twitter_misc":{"Written by":"Prakash","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sites.nd.edu\/pdnano\/?p=2118#article","isPartOf":{"@id":"https:\/\/sites.nd.edu\/pdnano\/?p=2118"},"author":{"name":"Prakash","@id":"https:\/\/sites.nd.edu\/pdnano\/#\/schema\/person\/3bec2d9fbd957b23abd53a0a5445b4f0"},"headline":"pdnano Lab Awarded BIPH Technology Bridge Fund for Ovarian Cancer Nanomedicine","datePublished":"2026-06-19T10:35:34+00:00","dateModified":"2026-06-19T10:35:35+00:00","mainEntityOfPage":{"@id":"https:\/\/sites.nd.edu\/pdnano\/?p=2118"},"wordCount":189,"image":{"@id":"https:\/\/sites.nd.edu\/pdnano\/?p=2118#primaryimage"},"thumbnailUrl":"http:\/\/sites.nd.edu\/pdnano\/files\/2026\/06\/scientific_nanoparticle_targeting_and_fluorescence_mg-cropped-251x300.png","keywords":["Berthiaume Institute for Precision Health","Nallathambylab","Nanomedicine","NotreDameResearch"],"articleSection":["Berthiaume Institute for Precision Health","Harper Cancer Research Institute","Hybrid nanoparticles","metastatic cancer cells"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/sites.nd.edu\/pdnano\/?p=2118","url":"https:\/\/sites.nd.edu\/pdnano\/?p=2118","name":"pdnano Lab Awarded BIPH Technology Bridge Fund for Ovarian Cancer Nanomedicine - Nallathamby Laboratory","isPartOf":{"@id":"https:\/\/sites.nd.edu\/pdnano\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sites.nd.edu\/pdnano\/?p=2118#primaryimage"},"image":{"@id":"https:\/\/sites.nd.edu\/pdnano\/?p=2118#primaryimage"},"thumbnailUrl":"http:\/\/sites.nd.edu\/pdnano\/files\/2026\/06\/scientific_nanoparticle_targeting_and_fluorescence_mg-cropped-251x300.png","datePublished":"2026-06-19T10:35:34+00:00","dateModified":"2026-06-19T10:35:35+00:00","author":{"@id":"https:\/\/sites.nd.edu\/pdnano\/#\/schema\/person\/3bec2d9fbd957b23abd53a0a5445b4f0"},"breadcrumb":{"@id":"https:\/\/sites.nd.edu\/pdnano\/?p=2118#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sites.nd.edu\/pdnano\/?p=2118"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sites.nd.edu\/pdnano\/?p=2118#primaryimage","url":"https:\/\/sites.nd.edu\/pdnano\/files\/2026\/06\/scientific_nanoparticle_targeting_and_fluorescence_mg-cropped.png","contentUrl":"https:\/\/sites.nd.edu\/pdnano\/files\/2026\/06\/scientific_nanoparticle_targeting_and_fluorescence_mg-cropped.png","width":596,"height":711},{"@type":"BreadcrumbList","@id":"https:\/\/sites.nd.edu\/pdnano\/?p=2118#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sites.nd.edu\/pdnano\/"},{"@type":"ListItem","position":2,"name":"pdnano Lab Awarded BIPH Technology Bridge Fund for Ovarian Cancer Nanomedicine"}]},{"@type":"WebSite","@id":"https:\/\/sites.nd.edu\/pdnano\/#website","url":"https:\/\/sites.nd.edu\/pdnano\/","name":"Modular Nanotechnologies and Nanomaterials","description":"Modular and scalable nanotechnology for imaging, sensing and therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sites.nd.edu\/pdnano\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/sites.nd.edu\/pdnano\/#\/schema\/person\/3bec2d9fbd957b23abd53a0a5445b4f0","name":"Prakash","url":"https:\/\/sites.nd.edu\/pdnano\/?author=2672"}]}},"_links":{"self":[{"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=\/wp\/v2\/posts\/2118","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=\/wp\/v2\/users\/2672"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2118"}],"version-history":[{"count":2,"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=\/wp\/v2\/posts\/2118\/revisions"}],"predecessor-version":[{"id":2121,"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=\/wp\/v2\/posts\/2118\/revisions\/2121"}],"wp:attachment":[{"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2118"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2118"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sites.nd.edu\/pdnano\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2118"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}